Good news for drug manufacturing company Norvatis as U.S. health regulators
said on Monday that they found
no evidence of increased
cardiovascular risks related to
Novartis AG's treatment, Stalevo,
for Parkinson's disease.
Norvatis are the manufacturer of the drug Stalevo which is used for
treating Parkinson's disease. The story would have been different if
the FDA have discovered that their drug linked to any cardiovascular
According to US research exercising two to three times a week (30 minutes per session) over a lifetime led to more youthful middle-sized ar...
A situation where there is a depletion of blood as a result of lack of hemoglobin is known as blood shortage. This a serious medical p...
A study conducted among about 460 cows and 3,130 abattoirs in Nigeria found that about 40 percent of herds surveyed carried bovine TB. Acc...
1. Mix 1 part of ginger powder with 1 part of honey. Take 1/2 teaspoon of the mix 3 times a day.This will help to enlarge your penis . ...